These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 15479907

  • 21. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H.
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [Abstract] [Full Text] [Related]

  • 22. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR.
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [Abstract] [Full Text] [Related]

  • 23. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 24. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C, Sato S, Takehara K.
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I, Dostal C, Becvar R.
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [Abstract] [Full Text] [Related]

  • 26. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
    Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K.
    Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
    [Abstract] [Full Text] [Related]

  • 27. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
    Nakamura M, Tanaka Y, Satoh T, Kawai M, Hirakata M, Kaburaki J, Kawakami Y, Ikeda Y, Kuwana M.
    Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
    [Abstract] [Full Text] [Related]

  • 28. Serum CCL23 levels are increased in patients with systemic sclerosis.
    Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Asano Y, Kadono T, Sato S.
    Arch Dermatol Res; 2011 Jan; 303(1):29-34. PubMed ID: 20824279
    [Abstract] [Full Text] [Related]

  • 29. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 30. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [Abstract] [Full Text] [Related]

  • 31. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 32. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Sep; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 33. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I, Jouen F, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [Abstract] [Full Text] [Related]

  • 34. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K.
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [Abstract] [Full Text] [Related]

  • 35. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S.
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [Abstract] [Full Text] [Related]

  • 36. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
    Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
    [Abstract] [Full Text] [Related]

  • 37. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome].
    Kaburaki J, Kuwana M, Ikeda Y.
    Rinsho Ketsueki; 2003 Jan; 44(1):28-30. PubMed ID: 12649835
    [Abstract] [Full Text] [Related]

  • 38. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [Abstract] [Full Text] [Related]

  • 39. Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.
    Chauhan R, Handa R, Das TP, Pati U.
    Clin Exp Immunol; 2004 Jun; 136(3):574-84. PubMed ID: 15147363
    [Abstract] [Full Text] [Related]

  • 40. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S, Hasegawa M, Nagaoka T, Takamatsu Y, Yazawa N, Ihn H, Kikuchi K, Takehara K.
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.